Page 182 - Patent Coverage News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Patent coverage. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Patent Coverage Today - Breaking & Trending Today

Federal Circuit Patent Watch: Pending, Non-final Litigation Or IPR Decision Does Not Negate Intent To Infringe That Is Otherwise Supported By Evidence - Patent

Lourie, J. The Court affirmed the district court's validity and infringement findings. The construction of the claim limitation "treating pulmonary hypertension" did not require a showing of safety and efficacy. ....

Key Federal Circuit , Federal Circuit Patent Watch Pending , On Final Litigation Or Ipr Decision Does Not Negate Intent To Infringe That Is Otherwise Supported By Evidence , Intellectual Property , Ediation Amp Arbitration , Trials Amp Appeals Compensation ,

Swiss court upholds Apple Inc. trademark appeal

The image of an apple may soon be trademarked in Switzerland. ....

Swiss Federal Institute For Intellectual Property , Apple Inc , Administrative Court , Federal Administrative Court , Swiss Federal Institute , Intellectual Property , Justice And Rights , Copyright And Trademark , International Law , Law And Order , Latest News , Antitrust Issue ,

Trends In Orange Book And Biologic PTAB Trials - Patent

The USPTO has released an updated report on Inter Partes Review (IPR) and Post Grant Review (PGR) proceedings involving Orange Book or biologic patents, taking into account data through. ....

Trends In Institution , Inter Partes Review , Post Grant Review , Orange Book , Orange Book Listed , Trends Tell , Purple Book Listed , Trends In Orange Book And Biologic Ptab Trials , Life Sciences , Life Sciences , Iotechnology Amp Nanotechnology , Intellectual Property ,

Status Of Reverse Payment Cases Against Pharmaceutical Companies - Patent

Reverse payment cases arise in the context of settlement agreements between brand-name pharmaceutical companies and generic drug manufacturers to resolve patent litigation under the Hatch-Waxman Act. ....

United States , Christopherm Holman , Lowenstein Sandler , Phillip Areeda , Jennifere Sturiale , Jonathan Lewis , Josh Morris , Zarema Jaramillo , Herbert Hovenkamp , Solvay Pharmaceuticals , Endo Pharmaceuticals Inc , Us District Court , Beecham Corp , Impax Labs Inc , Landmark Supreme Court Ruling On Drug , Unimed Pharmaceuticals , Abbott Laboratories , Actavis Inc , Us Supreme Court , Cephalon Inc , Watson Pharm Inc , Valley Drug Co , Plough Corp , Supreme Court , Us Court , Geneva Pharm Inc ,

Patent Interferences May Not Involve Pure AIA Patent - Patent

The Patent Office is not supposed to issue separate patents for the same invention to competing inventors. Several statutory provisions empower the Office to reject pre-AIA patent application claims of the later inventor. ....

Mirexus Biotechnologies Inc , Rockefeller University , Patent Office , Patent Trial , Appeal Board , Rockefeller Univ , Federal Circuit , Patent Act , Track One , Mirexus Biotechnologies , Patent Interferences May Not Involve Pure Aia , Intellectual Property ,